Richard Wilson is a Senior Research Fellow in the field of
proteomics and manager of the UTAS proteomics facility. He was awarded his PhD
in biochemistry from the University of Manchester (UK) in 1998. He is a
biochemist with a long-standing interest in cartilage biology and pathology and
many years of experience in the application of proteomics in a wide range of
biological contexts. He has been an invited speaker at the International
Cartilage Repair Society meeting. He has held his current appointment as
manager of the Central Science Laboratory proteomics mass spectrometry facility
at the University of Tasmania since 2011 and has an honorary appointment with
the Musculoskeletal Research Group at MCRI. He is a member of the Australasian
Proteomics Society and the Matrix Biology Society of Australia and New Zealand.
Luke Johnson obtained his PhD from the University of Oxford. He has held postdoctoral and academic positions at Yale University, New York University, and Uniformed Services University School of Medicine, Bethesda, Maryland, USA. He is currently an Assistant Professor of Psychiatry and Neuroscience, and a Scientist at the Center for the Study of Traumatic Stress (CSTS), at the Uniformed Services University (USU) in Bethesda, MD, USA. His current research is investigating the micro-circuitry of the amygdala and its encoding of fear memory.
Vanni Caruso is a medical researcher and Senior Lecturer in Pharmacology at the School of Pharmacy and Pharmacology, University of Tasmania. Before joining the University of Tasmania, he worked as a postdoctoral fellow at the Department of Neuroscience, Uppsala University (Sweden). He obtained his PhD at the UNSW, Sydney and his MPharm at the University of Bologna, Italy. He leads the teaching of Pharmacology within the School of Pharmacy and Pharmacology at the University of Tasmania, Australia. He was awarded two “Teaching merit certificates” in recognition of a meritorious contribution to the teaching programs of the University of Tasmania (2017 and 2020). He is currently developing an invertebrate model for drug discovery projects. His research interests are in the field of neuroendocrine diseases and converge on drug discovery projects for the cure of obesity.
